Core Biopsy Needles Market to Reach USD 1718 million by 2034 at 6.8% CAGR
From USD 950 million in 2025 to USD 1718 million in 2034, a 6.8% compound annual rate.
Market findings and research announcements from the CDI research team. Showing 25–36 of 82.
From USD 950 million in 2025 to USD 1718 million in 2034, a 6.8% compound annual rate.
Market reaches USD 21.65 billion by 2034, up from USD 10.85 billion in 2025, at a 8.05% CAGR.
Market reaches USD 119.59 billion by 2034, up from USD 54.8 billion in 2025, at a 9% CAGR.
Market reaches USD 4.736 billion by 2034, up from USD 2.05 billion in 2025, at a 9.78% CAGR.
Market reaches USD 2.92 billion by 2034, up from USD 1.65 billion in 2025, at a 6.46% CAGR.
Market reaches USD 576.1 billion by 2034, up from USD 178 billion in 2025, at a 14.5% CAGR.
From USD 36.5 billion in 2025 to USD 67.1 billion in 2034, a 7% compound annual rate.
Market reaches USD 3.704 billion by 2034, up from USD 1.9 billion in 2025, at a 7.7% CAGR.
Market reaches USD 17.35 billion by 2034, up from USD 8.5 billion in 2025, at a 8.31% CAGR.
Market reaches USD 942 million by 2034, up from USD 420 million in 2025, at a 9.4% CAGR.
Market reaches USD 3.62 billion by 2034, up from USD 1.78 billion in 2025, at a 8.19% CAGR.
From USD 4350 million in 2025 to USD 7993 million in 2034, a 7.07% compound annual rate.
For comment on a published finding, or to request the full study behind a release, contact the research team.